1 Market Overview

1.1 Product Overview and Scope of Diabetes Therapy and Drug Delivery

1.2 Classification of Diabetes Therapy and Drug Delivery by Type

1.2.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020

1.2.3 Inhalable Insulin

1.2.4 Oral Insulin

1.2.5 Insulin Patches

1.2.6 CGM Systems

1.2.7 Artificial Pancreas

1.3 Global Diabetes Therapy and Drug Delivery Market by Application

1.3.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnostic/Clinics

1.3.3 ICUs

1.3.4 Home Healthcare

1.4 Global Diabetes Therapy and Drug Delivery Market Size & Forecast

1.5 Global Diabetes Therapy and Drug Delivery Market Size and Forecast by Region

1.5.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Diabetes Therapy and Drug Delivery Market Size by Region, (2016-2021)

1.5.3 North America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)

1.5.4 Europe Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)

1.5.6 South America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Diabetes Therapy and Drug Delivery Market Drivers

1.6.2 Diabetes Therapy and Drug Delivery Market Restraints

1.6.3 Diabetes Therapy and Drug Delivery Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions

2.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Medtronic

2.2.1 Medtronic Details

2.2.2 Medtronic Major Business

2.2.3 Medtronic Diabetes Therapy and Drug Delivery Product and Solutions

2.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Medtronic Recent Developments and Future Plans

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Diabetes Therapy and Drug Delivery Product and Solutions

2.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Sanofi Recent Developments and Future Plans

2.4 Novo Nordisk

2.4.1 Novo Nordisk Details

2.4.2 Novo Nordisk Major Business

2.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions

2.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novo Nordisk Recent Developments and Future Plans

2.5 MannKind

2.5.1 MannKind Details

2.5.2 MannKind Major Business

2.5.3 MannKind Diabetes Therapy and Drug Delivery Product and Solutions

2.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 MannKind Recent Developments and Future Plans

2.6 Enteris BioPharma

2.6.1 Enteris BioPharma Details

2.6.2 Enteris BioPharma Major Business

2.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions

2.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Enteris BioPharma Recent Developments and Future Plans

2.7 Dexcom

2.7.1 Dexcom Details

2.7.2 Dexcom Major Business

2.7.3 Dexcom Diabetes Therapy and Drug Delivery Product and Solutions

2.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Dexcom Recent Developments and Future Plans

2.8 Senseonics Holding

2.8.1 Senseonics Holding Details

2.8.2 Senseonics Holding Major Business

2.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions

2.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Senseonics Holding Recent Developments and Future Plans

2.9 Medtech

2.9.1 Medtech Details

2.9.2 Medtech Major Business

2.9.3 Medtech Diabetes Therapy and Drug Delivery Product and Solutions

2.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Medtech Recent Developments and Future Plans

2.10 Johnson & Johnson

2.10.1 Johnson & Johnson Details

2.10.2 Johnson & Johnson Major Business

2.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions

2.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Johnson & Johnson Recent Developments and Future Plans

2.11 Synertech

2.11.1 Synertech Details

2.11.2 Synertech Major Business

2.11.3 Synertech Diabetes Therapy and Drug Delivery Product and Solutions

2.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Synertech Recent Developments and Future Plans

2.12 Zosano Pharma

2.12.1 Zosano Pharma Details

2.12.2 Zosano Pharma Major Business

2.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions

2.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Zosano Pharma Recent Developments and Future Plans

2.13 Relmada Therapeutics

2.13.1 Relmada Therapeutics Details

2.13.2 Relmada Therapeutics Major Business

2.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions

2.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Relmada Therapeutics Recent Developments and Future Plans

2.14 Eli Lilly

2.14.1 Eli Lilly Details

2.14.2 Eli Lilly Major Business

2.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions

2.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Eli Lilly Recent Developments and Future Plans

2.15 Transdermal Specialties

2.15.1 Transdermal Specialties Details

2.15.2 Transdermal Specialties Major Business

2.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions

2.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Transdermal Specialties Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Diabetes Therapy and Drug Delivery Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Diabetes Therapy and Drug Delivery Players Market Share

3.2.2 Top 10 Diabetes Therapy and Drug Delivery Players Market Share

3.2.3 Market Competition Trend

3.3 Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2016-2021)

4.2 Global Diabetes Therapy and Drug Delivery Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)

5.2 Diabetes Therapy and Drug Delivery Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)

6.2 North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)

6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country

6.3.1 North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)

6.3.2 United States Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)

7.2 Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)

7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country

7.3.1 Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)

7.3.2 Germany Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

7.3.3 France Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

7.3.5 Russia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

7.3.6 Italy Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)

8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)

8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region

8.3.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2026)

8.3.2 China Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8.3.3 Japan Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8.3.4 South Korea Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8.3.5 India Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

8.3.7 Australia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)

9.2 South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)

9.3 South America Diabetes Therapy and Drug Delivery Market Size by Country

9.3.1 South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)

9.3.2 Brazil Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

9.3.3 Argentina Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)

10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)

10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country

10.3.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)

10.3.2 Turkey Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

10.3.4 UAE Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Diabetes Therapy and Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Diabetes Therapy and Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Diabetes Therapy and Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Region (2016-2021)

Table 5. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions

Table 9. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Medtronic Corporate Information, Head Office, and Major Competitors

Table 11. Medtronic Major Business

Table 12. Medtronic Diabetes Therapy and Drug Delivery Product and Solutions

Table 13. Medtronic Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Sanofi Major Business

Table 16. Sanofi Diabetes Therapy and Drug Delivery Product and Solutions

Table 17. Sanofi Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 19. Novo Nordisk Major Business

Table 20. Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions

Table 21. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. MannKind Corporate Information, Head Office, and Major Competitors

Table 23. MannKind Major Business

Table 24. MannKind Diabetes Therapy and Drug Delivery Product and Solutions

Table 25. MannKind Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Enteris BioPharma Corporate Information, Head Office, and Major Competitors

Table 27. Enteris BioPharma Major Business

Table 28. Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions

Table 29. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Dexcom Corporate Information, Head Office, and Major Competitors

Table 31. Dexcom Major Business

Table 32. Dexcom Diabetes Therapy and Drug Delivery Product and Solutions

Table 33. Dexcom Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Senseonics Holding Corporate Information, Head Office, and Major Competitors

Table 35. Senseonics Holding Major Business

Table 36. Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions

Table 37. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Medtech Corporate Information, Head Office, and Major Competitors

Table 39. Medtech Major Business

Table 40. Medtech Diabetes Therapy and Drug Delivery Product and Solutions

Table 41. Medtech Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 43. Johnson & Johnson Major Business

Table 44. Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions

Table 45. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Synertech Corporate Information, Head Office, and Major Competitors

Table 47. Synertech Major Business

Table 48. Synertech Diabetes Therapy and Drug Delivery Product and Solutions

Table 49. Synertech Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Zosano Pharma Corporate Information, Head Office, and Major Competitors

Table 51. Zosano Pharma Major Business

Table 52. Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions

Table 53. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Relmada Therapeutics Corporate Information, Head Office, and Major Competitors

Table 55. Relmada Therapeutics Major Business

Table 56. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions

Table 57. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 59. Eli Lilly Major Business

Table 60. Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions

Table 61. Eli Lilly Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Transdermal Specialties Corporate Information, Head Office, and Major Competitors

Table 63. Transdermal Specialties Major Business

Table 64. Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions

Table 65. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Players (2019-2021)

Table 67. Global Diabetes Therapy and Drug Delivery Revenue Share by Players (2019-2021)

Table 68. Breakdown of Diabetes Therapy and Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided

Table 70. Diabetes Therapy and Drug Delivery Mergers & Acquisitions in the Past Five Years

Table 71. Diabetes Therapy and Drug Delivery New Entrants and Expansion Plans

Table 72. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Type (2016-2021)

Table 73. Global Diabetes Therapy and Drug Delivery Revenue Share by Type (2016-2021)

Table 74. Global Diabetes Therapy and Drug Delivery Revenue Forecast by Type (2021-2026)

Table 75. Global Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021)

Table 76. Global Diabetes Therapy and Drug Delivery Revenue Forecast by Application (2021-2026)

Table 77. North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Diabetes Therapy and Drug Delivery Picture

Figure 2. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020

Figure 3. Inhalable Insulin

Figure 4. Oral Insulin

Figure 5. Insulin Patches

Figure 6. CGM Systems

Figure 7. Artificial Pancreas

Figure 8. Diabetes Therapy and Drug Delivery Revenue Market Share by Application in 2020

Figure 9. Diagnostic/Clinics Picture

Figure 10. ICUs Picture

Figure 11. Home Healthcare Picture

Figure 12. Global Diabetes Therapy and Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Diabetes Therapy and Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)

Figure 15. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region in 2020

Figure 16. North America Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Diabetes Therapy and Drug Delivery Market Drivers

Figure 22. Diabetes Therapy and Drug Delivery Market Restraints

Figure 23. Diabetes Therapy and Drug Delivery Market Trends

Figure 24. Abbott Laboratories Recent Developments and Future Plans

Figure 25. Medtronic Recent Developments and Future Plans

Figure 26. Sanofi Recent Developments and Future Plans

Figure 27. Novo Nordisk Recent Developments and Future Plans

Figure 28. MannKind Recent Developments and Future Plans

Figure 29. Enteris BioPharma Recent Developments and Future Plans

Figure 30. Dexcom Recent Developments and Future Plans

Figure 31. Senseonics Holding Recent Developments and Future Plans

Figure 32. Medtech Recent Developments and Future Plans

Figure 33. Johnson & Johnson Recent Developments and Future Plans

Figure 34. Synertech Recent Developments and Future Plans

Figure 35. Zosano Pharma Recent Developments and Future Plans

Figure 36. Relmada Therapeutics Recent Developments and Future Plans

Figure 37. Eli Lilly Recent Developments and Future Plans

Figure 38. Transdermal Specialties Recent Developments and Future Plans

Figure 39. Global Diabetes Therapy and Drug Delivery Revenue Share by Players in 2020

Figure 40. Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players Diabetes Therapy and Drug Delivery Revenue Market Share in 2020

Figure 42. Global Top 10 Players Diabetes Therapy and Drug Delivery Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global Diabetes Therapy and Drug Delivery Revenue Share by Type in 2020

Figure 45. Global Diabetes Therapy and Drug Delivery Market Share Forecast by Type (2021-2026)

Figure 46. Global Diabetes Therapy and Drug Delivery Revenue Share by Application in 2020

Figure 47. Global Diabetes Therapy and Drug Delivery Market Share Forecast by Application (2021-2026)

Figure 48. North America Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)

Figure 49. North America Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)

Figure 50. North America Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 51. United States Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)

Figure 55. Europe Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)

Figure 56. Europe Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 57. Germany Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)

Figure 65. China Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)

Figure 72. South America Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)

Figure 73. South America Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)

Figure 79. Turkey Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source